Effect of chronic angiotensin converting enzyme inhibition on sympathetic nerve traffic and baroreflex control of the circulation in essential hypertension

Guido Grassi, Carlo Turri, Raffaella Dell'Oro, Maria Luisa Stella, Gianni B. Bolla, Giuseppe Mancia

Research output: Contribution to journalArticle

Abstract

Background. Human studies have shown that the blood pressure lowering effects of angiotensin converting enzyme inhibitors are accompanied by a reduction in plasma norepinephrine levels. Whether this is due to central or peripheral mechanisms is unknown, however. Objective. To evaluate the effects of chronic interference with the renin-angiotensin system on sympathetic nerve traffic and baroreflex control of vagal and adrenergic cardiovascular drive. Patients and methods. In 18 untreated mild to moderate essential hypertensive patients aged 48.5 ± 1.9 years (mean ± SEM), we measured mean arterial pressure (Finapres), heart rate (electrocardiogram), plasma renin activity (radioimmunoassay), plasma norepinephrine (high-performance liquid chromatography) and postganglionic muscle sympathetic nerve activity (microneurography at a peroneal nerve). In nine patients, measurements were performed before and after 2 months of oral administration of lisinopril (10 mg/day), while in the remaining nine patients they were performed before and after a 2 month observation period, without the drug administration. Measurements were performed at rest and during baroreflex stimulation and deactivation elicited by stepwise intravenous infusions of phenylephrine and nitroprusside, respectively. Results. Lisinopril induced a marked increase in plasma renin activity (from 1.1 ± 0.2 to 6.4 ± 1.3 ng/ml per h, P <0.01) and a reduction in mean arterial pressure (from 109.6 ± 3.1 to 98.7 ± 2.9 mmHg, P <0.01) without affecting the heart rate. Plasma norepinephrine and muscle sympathetic nerve activity values were not significantly different before and after lisinopril treatment (plasma norepinephrine values changed from 290.4 ± 39.2 to 308.1 ± 67.1 pg/ml; muscle sympathetic nerve activity changed from 56.4 ± 5.3 to 50.6 ± 6.6 bursts/100 heart beats). Neither the sympathoinhibitory nor the sympathoexcitatory responses to phenylephrine and nitroprusside were affected by lisinopril, nor the concomitant bradycardia and tachycardia. The curves relating mean arterial pressure to heart rate and muscle sympathetic nerve activity values during baroreceptor manipulation were shifted to the left, indicating a resetting of the baroreflex to the lower blood pressure values achieved during treatment. Conclusions. In essential hypertension, sympathetic nerve traffic is not affected by chronic angiotensin converting enzyme inhibitor treatment that effectively interferes with the renin-angiotensin system and lowers the elevated blood pressure. The baroreflex ability to modulate heart rate and central sympathetic outflow is also unaffected. These data argue against the existence of a central sympathoexcitatory effect of angiotensin II in this condition. They also indicate that antihypertensive treatment with an angiotensin converting enzyme inhibitor preserves autonomic reflex control, with favorable consequences for cardiovascular homeostasis.

Original languageEnglish
Pages (from-to)1789-1796
Number of pages8
JournalJournal of Hypertension
Volume16
Issue number12
DOIs
Publication statusPublished - Dec 1998

Fingerprint

Baroreflex
Peptidyl-Dipeptidase A
Lisinopril
Norepinephrine
Heart Rate
Angiotensin-Converting Enzyme Inhibitors
Arterial Pressure
Nitroprusside
Phenylephrine
Renin-Angiotensin System
Blood Pressure
Renin
Muscles
Peroneal Nerve
Pressoreceptors
Aptitude
Therapeutics
Bradycardia
Intravenous Infusions
Tachycardia

Keywords

  • Angiotensin converting enzyme inhibitors
  • Baroreflex
  • Renin-angiotensin system
  • Sympathetic nervous system

ASJC Scopus subject areas

  • Endocrinology
  • Internal Medicine

Cite this

Effect of chronic angiotensin converting enzyme inhibition on sympathetic nerve traffic and baroreflex control of the circulation in essential hypertension. / Grassi, Guido; Turri, Carlo; Dell'Oro, Raffaella; Stella, Maria Luisa; Bolla, Gianni B.; Mancia, Giuseppe.

In: Journal of Hypertension, Vol. 16, No. 12, 12.1998, p. 1789-1796.

Research output: Contribution to journalArticle

Grassi, Guido ; Turri, Carlo ; Dell'Oro, Raffaella ; Stella, Maria Luisa ; Bolla, Gianni B. ; Mancia, Giuseppe. / Effect of chronic angiotensin converting enzyme inhibition on sympathetic nerve traffic and baroreflex control of the circulation in essential hypertension. In: Journal of Hypertension. 1998 ; Vol. 16, No. 12. pp. 1789-1796.
@article{cd28dd5d14184a9ab101f2c1aac293b3,
title = "Effect of chronic angiotensin converting enzyme inhibition on sympathetic nerve traffic and baroreflex control of the circulation in essential hypertension",
abstract = "Background. Human studies have shown that the blood pressure lowering effects of angiotensin converting enzyme inhibitors are accompanied by a reduction in plasma norepinephrine levels. Whether this is due to central or peripheral mechanisms is unknown, however. Objective. To evaluate the effects of chronic interference with the renin-angiotensin system on sympathetic nerve traffic and baroreflex control of vagal and adrenergic cardiovascular drive. Patients and methods. In 18 untreated mild to moderate essential hypertensive patients aged 48.5 ± 1.9 years (mean ± SEM), we measured mean arterial pressure (Finapres), heart rate (electrocardiogram), plasma renin activity (radioimmunoassay), plasma norepinephrine (high-performance liquid chromatography) and postganglionic muscle sympathetic nerve activity (microneurography at a peroneal nerve). In nine patients, measurements were performed before and after 2 months of oral administration of lisinopril (10 mg/day), while in the remaining nine patients they were performed before and after a 2 month observation period, without the drug administration. Measurements were performed at rest and during baroreflex stimulation and deactivation elicited by stepwise intravenous infusions of phenylephrine and nitroprusside, respectively. Results. Lisinopril induced a marked increase in plasma renin activity (from 1.1 ± 0.2 to 6.4 ± 1.3 ng/ml per h, P <0.01) and a reduction in mean arterial pressure (from 109.6 ± 3.1 to 98.7 ± 2.9 mmHg, P <0.01) without affecting the heart rate. Plasma norepinephrine and muscle sympathetic nerve activity values were not significantly different before and after lisinopril treatment (plasma norepinephrine values changed from 290.4 ± 39.2 to 308.1 ± 67.1 pg/ml; muscle sympathetic nerve activity changed from 56.4 ± 5.3 to 50.6 ± 6.6 bursts/100 heart beats). Neither the sympathoinhibitory nor the sympathoexcitatory responses to phenylephrine and nitroprusside were affected by lisinopril, nor the concomitant bradycardia and tachycardia. The curves relating mean arterial pressure to heart rate and muscle sympathetic nerve activity values during baroreceptor manipulation were shifted to the left, indicating a resetting of the baroreflex to the lower blood pressure values achieved during treatment. Conclusions. In essential hypertension, sympathetic nerve traffic is not affected by chronic angiotensin converting enzyme inhibitor treatment that effectively interferes with the renin-angiotensin system and lowers the elevated blood pressure. The baroreflex ability to modulate heart rate and central sympathetic outflow is also unaffected. These data argue against the existence of a central sympathoexcitatory effect of angiotensin II in this condition. They also indicate that antihypertensive treatment with an angiotensin converting enzyme inhibitor preserves autonomic reflex control, with favorable consequences for cardiovascular homeostasis.",
keywords = "Angiotensin converting enzyme inhibitors, Baroreflex, Renin-angiotensin system, Sympathetic nervous system",
author = "Guido Grassi and Carlo Turri and Raffaella Dell'Oro and Stella, {Maria Luisa} and Bolla, {Gianni B.} and Giuseppe Mancia",
year = "1998",
month = "12",
doi = "10.1097/00004872-199816120-00012",
language = "English",
volume = "16",
pages = "1789--1796",
journal = "Journal of Hypertension",
issn = "0263-6352",
publisher = "Lippincott Williams and Wilkins",
number = "12",

}

TY - JOUR

T1 - Effect of chronic angiotensin converting enzyme inhibition on sympathetic nerve traffic and baroreflex control of the circulation in essential hypertension

AU - Grassi, Guido

AU - Turri, Carlo

AU - Dell'Oro, Raffaella

AU - Stella, Maria Luisa

AU - Bolla, Gianni B.

AU - Mancia, Giuseppe

PY - 1998/12

Y1 - 1998/12

N2 - Background. Human studies have shown that the blood pressure lowering effects of angiotensin converting enzyme inhibitors are accompanied by a reduction in plasma norepinephrine levels. Whether this is due to central or peripheral mechanisms is unknown, however. Objective. To evaluate the effects of chronic interference with the renin-angiotensin system on sympathetic nerve traffic and baroreflex control of vagal and adrenergic cardiovascular drive. Patients and methods. In 18 untreated mild to moderate essential hypertensive patients aged 48.5 ± 1.9 years (mean ± SEM), we measured mean arterial pressure (Finapres), heart rate (electrocardiogram), plasma renin activity (radioimmunoassay), plasma norepinephrine (high-performance liquid chromatography) and postganglionic muscle sympathetic nerve activity (microneurography at a peroneal nerve). In nine patients, measurements were performed before and after 2 months of oral administration of lisinopril (10 mg/day), while in the remaining nine patients they were performed before and after a 2 month observation period, without the drug administration. Measurements were performed at rest and during baroreflex stimulation and deactivation elicited by stepwise intravenous infusions of phenylephrine and nitroprusside, respectively. Results. Lisinopril induced a marked increase in plasma renin activity (from 1.1 ± 0.2 to 6.4 ± 1.3 ng/ml per h, P <0.01) and a reduction in mean arterial pressure (from 109.6 ± 3.1 to 98.7 ± 2.9 mmHg, P <0.01) without affecting the heart rate. Plasma norepinephrine and muscle sympathetic nerve activity values were not significantly different before and after lisinopril treatment (plasma norepinephrine values changed from 290.4 ± 39.2 to 308.1 ± 67.1 pg/ml; muscle sympathetic nerve activity changed from 56.4 ± 5.3 to 50.6 ± 6.6 bursts/100 heart beats). Neither the sympathoinhibitory nor the sympathoexcitatory responses to phenylephrine and nitroprusside were affected by lisinopril, nor the concomitant bradycardia and tachycardia. The curves relating mean arterial pressure to heart rate and muscle sympathetic nerve activity values during baroreceptor manipulation were shifted to the left, indicating a resetting of the baroreflex to the lower blood pressure values achieved during treatment. Conclusions. In essential hypertension, sympathetic nerve traffic is not affected by chronic angiotensin converting enzyme inhibitor treatment that effectively interferes with the renin-angiotensin system and lowers the elevated blood pressure. The baroreflex ability to modulate heart rate and central sympathetic outflow is also unaffected. These data argue against the existence of a central sympathoexcitatory effect of angiotensin II in this condition. They also indicate that antihypertensive treatment with an angiotensin converting enzyme inhibitor preserves autonomic reflex control, with favorable consequences for cardiovascular homeostasis.

AB - Background. Human studies have shown that the blood pressure lowering effects of angiotensin converting enzyme inhibitors are accompanied by a reduction in plasma norepinephrine levels. Whether this is due to central or peripheral mechanisms is unknown, however. Objective. To evaluate the effects of chronic interference with the renin-angiotensin system on sympathetic nerve traffic and baroreflex control of vagal and adrenergic cardiovascular drive. Patients and methods. In 18 untreated mild to moderate essential hypertensive patients aged 48.5 ± 1.9 years (mean ± SEM), we measured mean arterial pressure (Finapres), heart rate (electrocardiogram), plasma renin activity (radioimmunoassay), plasma norepinephrine (high-performance liquid chromatography) and postganglionic muscle sympathetic nerve activity (microneurography at a peroneal nerve). In nine patients, measurements were performed before and after 2 months of oral administration of lisinopril (10 mg/day), while in the remaining nine patients they were performed before and after a 2 month observation period, without the drug administration. Measurements were performed at rest and during baroreflex stimulation and deactivation elicited by stepwise intravenous infusions of phenylephrine and nitroprusside, respectively. Results. Lisinopril induced a marked increase in plasma renin activity (from 1.1 ± 0.2 to 6.4 ± 1.3 ng/ml per h, P <0.01) and a reduction in mean arterial pressure (from 109.6 ± 3.1 to 98.7 ± 2.9 mmHg, P <0.01) without affecting the heart rate. Plasma norepinephrine and muscle sympathetic nerve activity values were not significantly different before and after lisinopril treatment (plasma norepinephrine values changed from 290.4 ± 39.2 to 308.1 ± 67.1 pg/ml; muscle sympathetic nerve activity changed from 56.4 ± 5.3 to 50.6 ± 6.6 bursts/100 heart beats). Neither the sympathoinhibitory nor the sympathoexcitatory responses to phenylephrine and nitroprusside were affected by lisinopril, nor the concomitant bradycardia and tachycardia. The curves relating mean arterial pressure to heart rate and muscle sympathetic nerve activity values during baroreceptor manipulation were shifted to the left, indicating a resetting of the baroreflex to the lower blood pressure values achieved during treatment. Conclusions. In essential hypertension, sympathetic nerve traffic is not affected by chronic angiotensin converting enzyme inhibitor treatment that effectively interferes with the renin-angiotensin system and lowers the elevated blood pressure. The baroreflex ability to modulate heart rate and central sympathetic outflow is also unaffected. These data argue against the existence of a central sympathoexcitatory effect of angiotensin II in this condition. They also indicate that antihypertensive treatment with an angiotensin converting enzyme inhibitor preserves autonomic reflex control, with favorable consequences for cardiovascular homeostasis.

KW - Angiotensin converting enzyme inhibitors

KW - Baroreflex

KW - Renin-angiotensin system

KW - Sympathetic nervous system

UR - http://www.scopus.com/inward/record.url?scp=0031766112&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031766112&partnerID=8YFLogxK

U2 - 10.1097/00004872-199816120-00012

DO - 10.1097/00004872-199816120-00012

M3 - Article

C2 - 9869013

AN - SCOPUS:0031766112

VL - 16

SP - 1789

EP - 1796

JO - Journal of Hypertension

JF - Journal of Hypertension

SN - 0263-6352

IS - 12

ER -